Stacey Chernoff
Investor Relations
Replay available
Purple Innovation, Inc. (NASDAQ: PRPL) Q2 2025 earnings conference call, held 2025-07-29. Replay captured from the company's public earnings webcast.

Investor Relations
Analyst, Raymond James
Analyst, Oppenheimer
Analyst, KeyBank Capital Markets
Analyst, UBS
Chief Executive Officer
Chief Financial Officer
Analyst, Ross Capital Partners
Thank you. I would now like to turn the call over to Stacey Chernoff, Investor Relations. Please go ahead. Thank you for joining Purple Innovation's second quarter 2025 earnings call. A copy of our earnings press release is available on the Investor Relations section of Purple's website at www.purple.com. Before we begin, I'd like to remind you that certain statements made in this presentation are forward-looking statements. These statements reflect PURPLE Innovation's judgment and analysis as of today and are subject to a variety of risks and uncertainties that could cause actual results to differ materially from current expectations. We should not place undue reliance on these forward-looking statements. For more information, please refer to the risk factors outlined in our filings for the SEC. Additionally, today's presentation will reference non-GAAP financial measures, such as adjusted operating expenses, adjusted EBITDA, adjusted net loss, and adjusted net loss per share. Reconciliation of these measures to their most comparable gap measures can be found in the earnings release available on our website. With that, I'll turn the call over to Rob DiMartini, Purple Innovation's Chief Executive Officer. Thank you, Stacey. Good afternoon, everyone, and thank you for joining us. With me on today's call is our Chief Financial Officer, Todd Vogelson. We're pleased to share our second quarter results, which exceeded our expectations and improved sequentially from the first quarter in both revenue and adjusted EBITDA. Our second quarter revenue reached 105 million, representing a 12.6% decrease from the prior year, but a slight increase compared to last quarter. Within the decline in revenue were two positive elements of note. First, demand for Rejuvenate 2.0 surpassed e...